Generic medicinal products and pharmacovigilance

Like all medicinal products, generic medicinal products are submitted to surveillance, the so-called pharmacovigilance, with the aim of detecting, analysing and preventing adverse reactions while the medicinal product is on the market.

Competent authorities systematically monitor the risks and adverse reactions of all medicinal products, whether they are generic or original.

Adverse reactions of such medicinal products can be reported via the reporting system of the FAMHP. Incidentally, that system shows that the number of reports is similar for generic and original medicinal products.

More information
Reporting an adverse reaction of a medicinal product for human use
Reporting an adverse reaction of a medicinal product for veterinary use
 

Last updated on 10/02/2023